Global Markets for Medical Imaging Reagents and Analysis Equipment -- Focus on Ultrasound
- An overview of the imaging, diagnosing and medical markets, with a focus on ultrasound
- Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
- Discussion of each market and its applications by its need for diagnosis through imaging, regulatory environment, technology involved, market projections, and market share
- Examination of technological issues, including the latest trends and developments
- Acquisition strategies and collaborations by companies
- Evaluations of the strengths and weaknesses of each system/technology in light of new technologies, growing competition, and changing customer needs
- Comprehensive company profiles of key players in the industry.
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for medical imaging technologies, which includes both the imaging systems and the contrast agents. The key objective is to present a comprehensive analysis and future direction of imaging techniques as an important tool for the usage in medical diagnostic procedures.
This report explores present and future strategies within the medical imaging technology market, which includes X-ray imaging, ultrasound, computed tomography, magnetic resonance imaging and positron emission tomography. The improvisation of the market as well as the setbacks and needs of the market are discussed in this report. The classifications, comparisons, advantages and disadvantages and usage of these types of diagnostic methods are also listed in this report.
A detailed analysis of medical imaging industry structure has been conducted. Revenues are broken down by the region and sales figures are estimated for the five-year period from 2011 through 2017.
Applications for medical imaging technologies are also discussed separately in the report, with an emphasis of the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
Extensive research and new developments in the field of medical imaging technology has improved their usage in being able to be used as a prime diagnostic tool for various diseases and other medical conditions. Modern industries continue to explore the advantages of medical imaging technologies, leading to the steady market growth due to higher production of the imaging systems. This study is an update to the one published in January 2010.
R&D spending, along with increasing competition, new technologies, new advancements and new product launches have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of new technologies, growing competition and changing customer needs.
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
This study contributes to the areas of market growth in medical imaging (imaging systems and contrast agents) product manufacturers and users. Pharmaceutical, biotechnical companies, research institutes, hospitals and physicians will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others.
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of imaging systems and contrast agents technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Many companies were surveyed to obtain data for this study. Included were manufacturers and end users of medical imaging technologies in various types of disease sectors industries. Data were gathered from various industry sources. BCC spoke with officials within the industry, consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.
BCC ONLINE SERVICES
BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:
- Examine the complete BCC Research catalog of market research reports and place direct orders.
- Subscribe to any of BCC Research’s many industry newsletters.
- Read announcements of recently published reports and newly launched newsletters.
- Register for its well-known conferences.
- Request additional information on any BCC research product.
- Take advantage of special offers.
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or an endorsement of any given product or company. This information is intended to be as accurate as possible at the time it was written and was undertaken on a best-effort basis. The views expressed are those of the author and do not make any warranty, express or implied, for the accuracy, completeness, or usefulness of the information, or for the interpretation of data or its use by others. Projections involve risks and uncertainties that include but are not limited to technical risks associated with technology development, government regulatory approvals, and access to capital. The author assumes no responsibility for any losses or damages that may result from one’s reliance on this material.
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.